Pierrel operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pierrel with three other
pharmaceutical manufacturers in Europe:
Vistin Pharma ASA
sales of 176.69 million Norwegian Kroner [US$20.40 million]
Science In Sport Plc
of the United Kingdom
(£15.62 million [US$20.07 million]
of which 89%
was Core), and
Replek AD Skopje
based in Macedonia
(955.23 million Denar [US$17.53 million]
During the year ended December of 2017, sales at
Pierrel were 16.84 million Euro (US$18.96 million).
increase of 18.0%
versus 2016, when the company's sales were 14.27 million Euro.